CCH reduced the proportions of CD4+IL-10+ and FOXP3+IL-10+ cells, which was reversed by FMT and SCFA treatment (Fig. 6B, D), demonstrating that FMT and SCFA treatment promoted IL-10 expression in effector T cells, especially Tregs, after CCH. This evidence concerns the gene IL10 and columnar cell hyperplasia of the breast.